Abnormal distribution of the non-Aβ component of Alzheimer's disease amyloid precursor/α-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment

Laboratory Investigation

Volumn 78, Issue 9, 1998, Pages 1169-1177

  Takeda, Ayako ^a,c   Hashimoto, Makoto ^a   Mallory, Margaret ^a   Sundsumo, Mary ^a   Hansen, Lawrence ^a,b   Sisk, Abbyanne ^a   Masliah, Eliezer ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; FORMIC ACID; PROTEINASE K;

ALZHEIMER DISEASE; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; LEWY BODY; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ALPHA-SYNUCLEIN; CADAVER; CEREBRAL CORTEX; ENDOPEPTIDASE K; FORMIC ACIDS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE; SUBCELLULAR FRACTIONS; SYNUCLEINS; TISSUE DISTRIBUTION;

EID: 0031661141     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Baba M, Nakajo S, Tu P-H, Tomita T, Nakaya K, Lee VM-Y, Trojanowski JQ, and Iwatsubo T (1998). Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879-884.
2. Barry RA, Kent SBH, McKinley MP, Meyer RK, DeArmond SJ, Hood LE, and Prusiner SB (1986). Scrapie and cellular prion proteins share polypeptide epitopes. J Infect Dis 153:848-854.
3. Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, de la Monte S, Norenberg MD, and Schneck SA (1988). Diffuse Lewy body disease and progressive dementia. Neurology 38:1520-1528.
4. Dickson DW, Crystal H, Mattiace LA, Kress Y, Schwagerl A, Ksiezak-Reding H, Davies P, and Yen S-HC (1989). Diffuse Lewy body disease: Light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol 78: 572-584.
5. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, and Yen S-H (1991). Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: Light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 41:1402-1409.
6. Ebeling W, Hennrich N, Klockow M, Metz H, Orth HD, and Lang H (1974). Proteinase K from Tritirachium album Limber. Eur J Biochem 47:91-97.
7. Eggertson DE and Sima AAF (1986). Dementia with cerebral Lewy bodies: A mesocortical dopaminergic effect? Arch Neurol 43:524-527.
8. Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, Hill LR, and Hansen L (1994). The apolipoprotein E allele 4 is over-represented in patients with the Lewy body variant of Alzheimer's disease. Neurology 44:1950-1951.
9. Gaspar P and Graf F (1984). Dementia in idiopathic Parkinson's disease. Acta Neuropathol 64:43-52.
10. George JM, Jin H, Woods WS, and Clayton DF (1995). Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15:361-372.
11. Gibb WRG and Lees AJ (1988). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752.
12. Han H, Weinreb PH, and Lansbury PT Jr (1995). The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: Is NAC a common trigger or target in neurodegenerative disease? Chem Biol 2:163-169.
13. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thai L, Pay MM, Hofstetter R, and Klauber M (1990). The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity. Neurology 40:1-7.
14. Hashimoto M, Hsu LJ, Sisk A, Xia Y, Takeda A, Sundsmo M, and Masliah E (in press, 1998). Human recombinant NACP/ a-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease. Brain Res.
15. Hashimoto M, Yoshimoto M, Sisk A, Hsu LJ, Sundsmo M, Kittel A, Saitoh T, Miller A, and Masliah E (1997). NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation. Biochem Biophys Res Commun 237:611-616.
16. Hsu LJ, Mallory M, Xia Y, Veinbergs I, Hashimoto M, Yoshimoto M, Thai LJ, Saitoh T, and Masliah E (1998). Expression pattern of the non-Aβ component of Alzheimer's disease amyloid precursor protein (NACP/α-synuclein) during brain development. J Neurochem 71:338-344.
17. Irizarry MC, Kim TW, McNamara M, Tanzi RE, George JM, Clayton DF, and Hyman BT (1996). Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol 55:889-895.
18. Iwai A, Masliah E, Yoshimoto M, De Silva R, Ge N, Kittel A, and Saitoh T (1994). The precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) is a presynaptic protein of the central nervous system. Neuron 14:467-475.
19. Jensen PH, Hojrup P, Hager H, Nielsen MS, Jacobsen L, Olesen OF, Gliemann J, and Jakes R (1997). Binding of Aβ to α- and β-synucleins: Identification of segments in α-synuclein/NAC precursor that bind Ab and NAC. Biochem J 323:539-546.
20. Kim H, Gearing M, and Mirra SS (1995). Ubiqutin-positive CA2/3 neurites in hippocampus coexist with cortical Lewy bodies. Neurology 45:1768-1770.
21. Kim J (1997). Evidence that the precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil. Mol Cells 7:78-83.
22. Kitamoto T, Ogomori K, Tateishi J, and Prusiner SB (1987). Formic acid pretreatment enhances imunostaining of cerebral and systemic amyloids. Lab Invest 57:230-236.
23. Kosaka K (1978). Lewy bodies in cerebral cortex: Report of three cases. Acta Neuropathol (Berl) 42:127-134.
24. Kosaka K, Yoshimura M, Ikeda K, and Budka H (1984). Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree - A new disease? Clin Neuropathol 3:183-192.
25. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, and Reiss O (1998). Ala30Pro mutation in the gene encoding α-synuclein in Parkinsons's disease. Nature Genet 18:106-108.
26. Langlais PJ, Thai L, Hansen L, Galasko D, Alford M, and Masliah E (1993). Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology 43:1927-1934.
27. Maroteaux L, Campanelli JT, and Scheller RH (1988). Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804-2815.
28. Maroteaux L and Scheller RH (1991). The rat brain synucleins: Family of proteins transiently associated with neuronal membrane. Mol Brain Res 11:335-343.
29. Masliah E, Iwai A, Mallory M, Ueda K, and Saitoh T (1996a). Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. Am J Pathol 148:201-210.
30. Masliah E, Mallory M, Alford M, DeTeresa R, Iwai A, and Saitoh T (1997). Molecular mechanisms of synaptic disconnection in Alzheimer's disease. In: Hyman BT, Duyckaerts C, and Christen Y, editors. Connections, cognition and Alzheimer's disease. Berlin: Springer-Verlag, 121-140.
31. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, and Games D (1996b). Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J Neurosci 16:5795-5811.
32. Masters CL, Simms G, Weidemann A, Multhaup G, McDonald BL, and Beyreuther K (1985). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245-4249.
33. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, de Vos RAI, Wilcock GK, Jellinger KA, and Perry RH (1996). Clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the CDLB International Workshop. Neurology 47:1113-1124.
34. Meltzer JC, Grimm PC, Greenberg AH, and Nance DM (1997). Enhanced immunohistochemical detection of autonomic nerve fibers, cytokines and inducible nitric oxide synthase by light and fluorescent microscopy in rat spleen. J Histochem Cytochem 45:599-610.
35. Mena R, Edwards P, Perez-Olvera O, and Wischik CM (1993). Monitoring pathological assembly of tau and β-amyloid proteins in Alzheimer's disease. Acta Neuropathol 89:50-56.
36. Nakajo S, Tsukada K, Omata K, Nakamura Y, and Nakaya K (1993). A new brain-specific 14-kDa protein is a phosphoprotein: Its complete amino acid sequence and evidence for phosphorylation. Eur J Biochem 217:1057-1063.
37. Paik SR, Lee JH, Kim DH, Chang CS, and Kim J (1997). Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid. Arch Biochem Biophys 344:325-334.
38. Pollanen MS, Dickson DW, and Bergeron C (1993). Pathology and biology of the Levy body. J Neuropathol Exp Neurol 52:183-191.
39. Polymeropoulos MH, Lavedant C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di lorio G, Golbe LI, and Nussbaum RL (1997). Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
40. Saitoh T, Xia Y, Masliah E, Terry R, Galasko D, Shults C, Hill R, Thal L, Hansen L, and Katzman R (1995). Association of the CYP2D6B mutant allele with Lewy body variant of Alzheimer's disease. Ann Neurol 37:110-112.
41. Schmidt ML, Murray J, Lee VM-Y, Hill WD, Wertkin A, and Trojanowski JQ (1991). Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 139:53-65.
42. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, and Goedert M (1997). α-Synuclein in Lewy bodies. Nature 388:839-840.
43. Spillantini MG, Crowther RA, Jakes R, and Hasegawa M (1998). α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469-6473.
44. Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, and Masliah E (1998). Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am J Pathol 152: 367-372.
45. Tashima T, Kitamoto T, Tateishi J, and Sato Y (1986). Congophilia in cerebral amyloidosis is modified by inactivation procedures on slow transmissible pathogens. Brain Res 399:80-86.
46. Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Otero D, Kondo J, Ihara Y, and Saitoh T (1993). Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease. Proc Natl Acad Sci USA 90:11282-11286.
47. Wakabayashi K, Honer WG, and Masliah E (1994). Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease. Brain Res 667:24-32.
48. Weinreb PH, Zhen W, Poon AW, Conway KA, and Lansbury PT Jr (1996). NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35:13709-13715.
49. Yoshimoto M, Iwai A, Kang D, Otero DAC, Xia Y, and Saitoh T (1995). NACP, the precursor protein of non-amyloid β/A4 protein (Aβ) component of Alzheimer disease amyloid, binds Aβ and stimulates Aβ aggregation. Proc Natl Acad Sci USA 92:9141-9145.
50. Yoshimura M (1983). Cortical changes in the parkinsonian brain: A contribution to the delineation of "diffuse Lewy body disease". J Neurol 229:17-32.